View Cart  

FDA Reopens DTC Ad Rule Comment Period

A A
Drugmakers have until Feb. 26 to submit additional comments on a proposed rule that establishes standards for the presentation of risk information in direct-to-consumer (DTC) television and radio advertisements.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00